Chularat Hospital Crescita futura

Future criteri di controllo 2/6

Chularat Hospital prevede che gli utili e i ricavi cresceranno rispettivamente di 10.1% e 7.2% all'anno. Si prevede che l'EPS crescerà di 8.3% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 16.4% in 3 anni.

Informazioni chiave

10.1%

Tasso di crescita degli utili

8.3%

Tasso di crescita dell'EPS

Healthcare crescita degli utili	9.9%
Tasso di crescita dei ricavi	7.2%
Rendimento futuro del capitale proprio	16.4%
Copertura analitica	Good
Ultimo aggiornamento	22 Nov 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Previsioni di crescita degli utili e dei ricavi

SET:CHG - Stime future degli analisti e dati finanziari passati (THB Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	10,101	1,407	1,240	1,890	8
12/31/2025	9,381	1,299	1,169	1,729	10
12/31/2024	8,460	1,089	796	1,677	6
9/30/2024	8,733	1,147	1,196	1,849	N/A
6/30/2024	8,520	1,056	932	1,841	N/A
3/31/2024	8,332	1,070	755	1,809	N/A
12/31/2023	8,014	1,046	952	2,087	N/A
9/30/2023	7,643	1,058	1,764	3,021	N/A
6/30/2023	7,574	990	1,880	2,951	N/A
3/31/2023	8,558	1,662	1,056	1,930	N/A
12/31/2022	10,408	2,778	1,806	2,629	N/A
9/30/2022	12,526	4,306	3,525	4,226	N/A
6/30/2022	14,883	5,611	3,167	3,779	N/A
3/31/2022	14,166	5,309	4,401	5,015	N/A
12/31/2021	11,999	4,204	3,522	4,005	N/A
9/30/2021	9,589	2,645	1,254	1,615	N/A
6/30/2021	6,598	1,363	1,423	1,721	N/A
3/31/2021	5,612	942	1,243	1,498	N/A
12/31/2020	5,462	877	1,004	1,298	N/A
9/30/2020	5,270	757	627	1,092	N/A
6/30/2020	5,241	744	518	1,122	N/A
3/31/2020	5,277	712	391	1,026	N/A
12/31/2019	5,188	705	241	974	N/A
9/30/2019	4,998	683	122	735	N/A
6/30/2019	4,715	565	119	715	N/A
3/31/2019	4,575	620	14	705	N/A
12/31/2018	4,427	634	45	695	N/A
9/30/2018	4,305	648	167	862	N/A
6/30/2018	4,187	665	N/A	952	N/A
3/31/2018	4,038	606	N/A	925	N/A
12/31/2017	3,894	565	N/A	910	N/A
9/30/2017	3,790	571	N/A	849	N/A
6/30/2017	3,721	563	N/A	805	N/A
3/31/2017	3,705	560	N/A	660	N/A
12/31/2016	3,655	564	N/A	705	N/A
9/30/2016	3,595	575	N/A	860	N/A
6/30/2016	3,436	536	N/A	704	N/A
3/31/2016	3,326	562	N/A	785	N/A
12/31/2015	3,171	538	N/A	698	N/A
9/30/2015	3,020	508	N/A	444	N/A
6/30/2015	2,904	514	N/A	555	N/A
3/31/2015	2,783	490	N/A	515	N/A
12/31/2014	2,695	481	N/A	446	N/A
9/30/2014	2,580	476	N/A	486	N/A
6/30/2014	2,497	475	N/A	368	N/A
3/31/2014	2,374	448	N/A	285	N/A
12/31/2013	2,234	414	N/A	309	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di CHG ( 10.1% all'anno) è superiore al tasso di risparmio ( 2% ).

Guadagni vs Mercato: Si prevede che gli utili di CHG ( 10.1% all'anno) cresceranno più lentamente rispetto al mercato TH ( 17.8% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di CHG cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di CHG ( 7.2% all'anno) crescerà più rapidamente del mercato TH ( 6.9% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di CHG ( 7.2% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di CHG sarà basso tra 3 anni ( 16.4 %).

Chularat Hospital Crescita futura

Future criteri di controllo 2/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Price target decreased by 7.2% to ฿3.85

Consensus EPS estimates increase by 18%

Consensus EPS estimates increase by 27%

Consensus forecasts updated

Recent updates

Third quarter 2024 earnings: EPS in line with expectations, revenues disappoint

Now 21% overvalued after recent price rise

First half dividend of ฿0.02 announced

Second quarter 2024 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2024 to 30 June 2024, Payable on September 13, 2024

First quarter 2024 earnings released: EPS: ฿0.024 (vs ฿0.022 in 1Q 2023)

Now 22% overvalued

Now 21% overvalued

Now 21% overvalued

Final dividend of ฿0.05 announced

Full year 2023 earnings: EPS misses analyst expectations

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 26, 2024

Chularat Hospital Public Company Limited Approves Appointment of the Directors of Sub-Committees

Third quarter 2023 earnings: EPS exceeds analyst expectations

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 11%

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Chularat Hospital Public Company Limited Approves an Interim Dividend for the Six-Month Period Ended 30 June 2023, Payable on 8 September 2023

Price target decreased by 7.2% to ฿3.85

First quarter 2023 earnings: EPS misses analyst expectations

Upcoming dividend of ฿0.075 per share at 4.4% yield

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Chularat Hospital Public Company Limited Appoints Wandee Pisanuvanavech as Deputy Chief Executive Officer

Chularat Hospital Public Company Limited Announces Executive Changes

Upcoming dividend of ฿0.085 per share

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Chularat Hospital Public Company Limited Approves Interim Dividend for the Period from 1 January 2022 to 30 June 2022, Payable on September 9, 2022

Chularat Hospital Public Company Limited Appoints Santhat Sanguandikul as Member of the Audit Committee

Consensus EPS estimates increase by 18%

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of ฿0.17 per share

Less than half of directors are independent

Consensus EPS estimates increase by 27%

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Chularat Hospital Public Company Limited Proposes Interim Dividend, Payable on or Before May 20, 2022

Third quarter 2021 earnings released: EPS ฿0.14 (vs ฿0.026 in 3Q 2020)

Upcoming dividend of ฿0.03 per share

Consensus forecasts updated

Price target increased to ฿4.27

Chularat Hospital Public Company Limited (SET:CHG) acquired additional 10% stake in Ruampat Mae Sot International Company.

Consensus EPS estimates increase to ฿0.10

First quarter 2021 earnings released: EPS ฿0.023 (vs ฿0.017 in 1Q 2020)

Upcoming dividend of ฿0.03 per share

New 90-day high: ฿2.78

Full year 2020 earnings released: EPS ฿0.08 (vs ฿0.064 in FY 2019)

Chularat Hospital Public Company Limited, Annual General Meeting, Apr 23, 2021

New 90-day high: ฿2.74

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS ฿0.026

Upcoming Dividend of ฿0.02 Per Share

First half earnings released

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita